Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Article
Brief Report
Case Report
Commentary
Community Case Study
Editorial
Image
Images
Letter to Editor
Letter to the Editor
Media & News
Mini Review
Obituary
Original Article
Perspective
Review Article
Reviewers; List
Short Communication
Task Force Report
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Article
Brief Report
Case Report
Commentary
Community Case Study
Editorial
Image
Images
Letter to Editor
Letter to the Editor
Media & News
Mini Review
Obituary
Original Article
Perspective
Review Article
Reviewers; List
Short Communication
Task Force Report
View/Download PDF

Translate this page into:

Review Article
61 (
4
); 314-320
doi:
10.25259/ANAMS-2023-4-5-(886)

Spatio-temporal effects of iodine/thyroid hormone deficiency on neurodevelopment and plausible amelioration approaches beyond the critical window

Distinguished Professor, Karnataka Lingayat Education Deemed University, Belagavi, Karnataka, India
All Biosciences Research Pvt Ltd, Haryana, India
Amity Institute of Neuropsychology and Neurosciences Amity University, Noida, Uttar Pradesh, India
Department of Neurology, UT Southwestern Medical Center, TX, Dallas, United States
Department of Endocrinology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
Department of Neurology, Feinberg School of Medicine Northwestern University, IL, United States

*Corresponding author: Prof. Madan M Godbole, Distinguished Professor, Karnataka Lingayat Education Deemed University, Belagavi, Karnataka, India. godboleumg@kledeemeduniversity.edu.in

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Godbole MM, Pal A, Pathak A, Kumar P, Sinha RA, Mohan V. Spatio-temporal effects of iodine/thyroid hormone deficiency on neurodevelopment and plausible amelioration approaches beyond the critical window. Ann Natl Acad Med Sci (India). 2025;61:314-20. doi: 10.25259/ANAMS-2023-4-5-(886)

Abstract

Thyroid hormones (TH) are key endocrine players in mammalian brain development. They regulate the cellular and molecular aspects of several dynamic neurodevelopmental processes, including neurogenesis, neuronal migration, astrogliogenesis, synaptogenesis, neuronal apoptosis, and myelination in a very precise spatiotemporal manner. Therefore, TH deficiency during early brain development leads to severe and often irreversible mental disabilities in humans. Additionally, the requirement of TH for the development of different brain areas is also unique. This spatio-temporal dependence of neurodevelopment on maternal and fetal TH availability introduced the concept of a “critical window,” which refers to a time frame during the development of the brain wherein the availability of TH is indispensable. In this review, we cover our recent understanding of the spatio-temporal spectrum of TH-dependent neocortical and cerebellar development, along with the use of omega-3-fatty acids and histone deacetylase inhibitors to mitigate the impact of hypothyroidism on mammalian brain development.

Keywords

Apoptosis
Cerebellum
Critical window
Iodine/Thyroid hormone deficiency
HDAC inhibition
Neuronal development
Neurogenesis
Neuronal migration
Neocortex
Omega-3-fatty acids
Reelin

INTRODUCTION

Iodine is an essential micronutrient required to synthesize thyroid hormones (THs), thyroxine (T4), and triiodothyronine (T3) in mammals. Iodine deficiency is still a major nutritional deficiency around the world, despite extensive salt-iodination programs in several countries, including India.1,2 From a public health perspective, iodine deficiency disorders (IDD) during early fetal and neonatal periods of life lead to brain damage and disrupted intellectual development.3 At the molecular level, thyroxine (T4) of both maternal and fetal origin crosses the blood-brain barrier into the brain cells via TH transporters like the monocarboxylate transporter 8 (MCT8) in humans, and also the organic anion-transporting polypeptide 1c1 (OATP1C1) in rodents.4 It is believed that most of the T3 inside the astrocytes and neurons is derived by intracellular deiodination of T4 by deiodinase 2 (DIO2) expressed in glial cells, including astrocytes and tanycytes.5, 6 At the same time, neurons express deiodinase 3 (DIO3), which prevents the over-accumulation of T3 within neurons.7,8 T3 is the biologically active form of TH, which regulates the genomic control of neuronal and glial genes involved in neurodevelopmental processes.9 Transcriptional regulation of gene expression by T3 during brain maturation is executed by the action of TH receptor0 alpha (THRα1) and beta (THRβ1 and THRβ2), which bind to cognate DNA sequences known as TH response elements (TRE) in the promoter region of the target genes during embryonic and postnatal brain development.9,10 Upon binding to the TRE, TH receptors recruit the co-activator complex with histone acetylase (HAT) activity, resulting in unwinding of nucleosomes and RNA Pol II-mediated transcription.9 However, in the absence of T3, which represents a hypothyroid state, THRs act as “aporeceptor” and recruit a co-repressor complex with histone deacetylase (HDAC) activity and repress basal gene expression in the developing brain.9 Rodents and humans differ in the distribution of THR isoforms during development, with THRα1 being the predominant receptor in the developing rodent brain; THRβ1 is more enriched in humans.10,11 Interestingly, THRs are themselves modulated by TH levels during early brain development.12 There are different sets of T3-responsive genes during the fetal and postnatal developmental periods. During fetal development, several genes of the Camk4 signaling pathways are responsive to T3, and during the postnatal period genes like Adamtsl4, Dbp, Fos, Hr, Kcna1, Klf9, Scd1, Stat5a, and Txnip, Shh, Dbp, Gbp3, and Nrgn have been shown to be T3 responsive. Besides the classical genomic action of T3, non-genomic action of T4 also exerts profound cellular effects during brain development.13,14 Functional studies from women residing in iodine-deficient geographical areas indicate that iodine administration to pregnant women is most effective for the developing brain of the fetus during the first trimester of pregnancy compared to later stages.3 The results from our research on hypothyroid rats also demonstrated the requirement of adequate TH levels during the critical window of cortical development and advocated timely TH administration to prevent neurogenesis and neuronal migration defects due to TH deficiency.1517 These findings collectively indicate that maternal TH exerts a profound role in brain development before the onset of fetal thyroid function (FTF) during the early phases of neocortical development. Similarly, the TH-sensitive period during cerebellar development in humans, spanning the last trimester of fetal development and the first few months of neonatal life, and in the rats during the first two postnatal weeks of development, is sensitive to circulating TH levels. In humans, TH replacement in congenitally hypothyroid infants, if done immediately after birth, results in near-normal intellectual development but fails if delayed even for a few days.18 This tight dependence of the neurological developmental on circulating TH levels may be due to a highly precise temporal regulation of genes involved in the developmental processes by THRs. These developmental processes, regulated by TH, include neurogenesis, neuronal differentiation, neuronal migration, astrogliogenesis, synaptogenesis, neuronal apoptosis, and myelination. We present the work done by us and others on maternal and fetal TH action on neocortical and cerebellar development and recent paradigms of preventing the deleterious effects of hypothyroidism by epigenetic modifiers and omega-3-fatty acids.

TH and cerebral cortex development

Cerebral cortex (neocortex) development is an immensely fine-tuned process wherein different neural cell types originate from precursors and migrate to specific brain regions to form cohesive functional circuits.19

Previous studies from hypothyroid rats showed the lack of well-defined cortical layers due to aberrant neuronal migration, resulting in altered neural circuitry and brain function.20 Here we reviewed the necessity of the TH for the developing cerebral cortex with the recent updates regarding the cellular and molecular action of TH on the neuroglial cells as discovered by us and other groups, with highlights of our novel findings on maternal TH-dependent neurogenesis and neuronal migration in the embryonic brain before FTF.

Maternal TH & neurogenesis

The commencement of cortical neurogenesis involves two modes of cell division of neuronal progenitors that give rise to all glutamatergic neurons.21 These two modes of cell division include either direct neurogenesis, wherein neuronal progenitors at the ventricular zone, known as radial glial cells (RG), undergo asymmetric division giving rise to another RG and one neuronal progeny or indirect neurogenesis where RG asymmetric division produces an intermediate progenitors cells (IPCs), which then undergo symmetric division to generate two neurons within the intermediate zone and contribute to cortical thickness.21 The period for neocortical neurogenesis is between embryonic day (ED) 12 to 18, which is mostly complete before the start of FTF at E17.5 in rats; these are largely dependent on maternal TH availability. The early expression of MCT8,22 DIO2,23 and THRα110 all coincides with the process of neurogenesis in the developing rodent cerebral cortex. Past studies showed a strong association between maternal T4 insufficiency and impaired neocorticogenesis.24,25 Adding new insight into this aspect, we demonstrated that maternal TH deficiency causes disrupted cell cycle kinetics and deranged neurogenesis in rat models of maternal hypothyroidism.17 We showed that maternal hypothyroidism specifically affects indirect neurogenesis governed by IPCs.17 Our results demonstrated that both IPCs' abundance and their differentiation into neurons were significantly compromised under maternal hypothyroidism.17 One of the mechanisms as to why neuronal progenitors are reduced under maternal hypothyroidism was due to increased apoptosis. This result was also supported by our earlier finding, wherein we found increased expression of neuronal nitric oxide synthase and its association with increased neuronal cell death in the developing neocortex under maternal hypothyroidism.15 Additionally, we showed that the IPCs pool, giving rise to neurons. This is determined by the cleavage orientation (symmetrical vs. asymmetrical) of neuronal progenitors and is dependent on maternal TH availability. Our results showed that the temporal dynamics of both symmetrical and asymmetrical cell division of IPCs are altered under maternal hypothyroidism and can be corrected upon timely T4 supplementation, resulting in normalization of IPC cell division and neurogenesis17 [Figure 1]. Therefore, in summary, our study showed that IPCs maintain cortical thickness through indirect neurogenesis and provide for fine-tuning of brain functions that may suffer from maternal TH deficiency if not corrected early during development.

Maternal TH (MTH) affects early progenitor population and their divisions. (a) Photomicrographs show nestin (marker of progenitors) immunofluorescence at E14. A marked reduction in the nestin staining in the VZ of hypothyroid fetal cortex, along with thinner and stunted filaments compared to euthyroid. Scale bars 50 μM. (b) Hoechst staining showing symmetrical (vertical) and asymmetrical (horizontal and oblique) cleavages. Counting was done at ventricular surface within the area flanked by red arrows. White square denotes the inset of the area magnified. (c) Under MTH deficiency, symmetrical division was significantly less at E14 (p<0.05) while increasing at E18 (**p<0.05). (d) Asymmetrical divisions reduced from E14 to E18 (**p<0.005), interestingly on T4 treatment from E11-E13, E13-E15 and E15-E17, both symmetrical and asymmetrical divisions restored back to normal at E14, E16 and E18 respectively. The arrow in the panel b denotes plane of cleavage. The y-axis in panel c is the number of symmetrical cleavage/division and in the panel d shows the number of asymmetrical cleavage. The x-axis in panel c and d depicts embryonic days. “*” in panel c and d denotes p<0.05. (Reproduced by permission from: https://www.sciencedirect.com/science/article/abs/pii/S0014488612003056).
Figure 1:
Maternal TH (MTH) affects early progenitor population and their divisions. (a) Photomicrographs show nestin (marker of progenitors) immunofluorescence at E14. A marked reduction in the nestin staining in the VZ of hypothyroid fetal cortex, along with thinner and stunted filaments compared to euthyroid. Scale bars 50 μM. (b) Hoechst staining showing symmetrical (vertical) and asymmetrical (horizontal and oblique) cleavages. Counting was done at ventricular surface within the area flanked by red arrows. White square denotes the inset of the area magnified. (c) Under MTH deficiency, symmetrical division was significantly less at E14 (p<0.05) while increasing at E18 (**p<0.05). (d) Asymmetrical divisions reduced from E14 to E18 (**p<0.005), interestingly on T4 treatment from E11-E13, E13-E15 and E15-E17, both symmetrical and asymmetrical divisions restored back to normal at E14, E16 and E18 respectively. The arrow in the panel b denotes plane of cleavage. The y-axis in panel c is the number of symmetrical cleavage/division and in the panel d shows the number of asymmetrical cleavage. The x-axis in panel c and d depicts embryonic days. “*” in panel c and d denotes p<0.05. (Reproduced by permission from: https://www.sciencedirect.com/science/article/abs/pii/S0014488612003056).

Maternal TH & neuronal migration

Post-neurogenesis during cerebral cortex development, neurons born near the ventricular and sub-ventricular regions migrate radially, forming the six-layered cortical plate. During normal brain development, the extracellular protein, Reelin, secreted by the Cajal-Retzius (CR) neurons located in the marginal zone, plays a guiding role in neuronal migration and neocortical lamination.26 The Reelin signaling cascade involves the binding of Reelin protein to the lipoprotein receptors, apolipoprotein E receptor 2 (ApoER2) and very low-density lipoprotein receptor (VLDLR), followed by phosphorylation of the disabled 1(Dab1) adaptor protein in the receptive migrating glutamatergic neurons.26 Maternal TH plays a vital role in regulating neuronal migration during neocortical development;27 however, the molecular events mediating morphogenic actions and the mechanism regulating reelin down-regulation under hypothyroidism remained unclear. To understand the cellular and molecular mechanisms behind the impaired migration of neurons under maternal hypothyroidism, we investigated the morphology of migrating neurons and their glial scaffolds with emphasis on the involvement of reelin signaling in the developing rat brains during the critical window period of neuronal migration. The hypothyroid fetuses isolated from hypothyroid dams showed aberrant neuronal migration due to loss of neuronal bipolarity and decrease in the number and length of radial glia, which was correctible after T4 replacement only in early gestational stages, from embryonic day 13-15 in rats.16 The decrease in reelin levels in hypothyroid brains led us to hypothesize that the decreased reelin levels likely result from increased apoptosis in reelin-secreting CR neurons or compromised neurotrophin signaling by brain-derived neurotrophin factor (BDNF). Interestingly, we did not observe any evidence of increased cell death of CR neurons nor any down-regulation in BDNF expression.16 Puzzled by the decrease in reelin levels in the hypothyroid brain, which can be corrected by T4 replacement, we checked if the reln gene was a direct THR target. Following bioinformatic analysis and gel shift assay, the chromatin immunoprecipitation assays indicated a TRE and physiological binding site of THRα on the reln gene and possible transcriptional control of reelin by TH.16 TH deficiency significantly reduced the expression of reelin receptors, ApoER2 and VLDLR, along with a decrease in the activation of adaptor Dab1 that further compromised the reelin signaling in the developing brain. These results helped us to understand the mechanistic basis for the requirement of adequate maternal TH levels to ensure proper fetal neocortical cytoarchitecture via proper migration of neurons.16 These findings were further supported by recent reports from other research groups, reinforcing that TH action targets multiple components in the developing brain through both genomic and nongenomic mechanisms.28

TH regulated programmed cell death in developing cerebellum at its modulation by omega-3-fatty acids

The developmental process affected by TH insufficiency in the cerebellum is delayed migration of granule cells to the inner granule layer, defective dendritic arborization of Purkinje neurons, delayed myelination, and increased apoptosis of granule cells within the inner granule layer.29 Our work on apoptosis-mediated pruning of neurons during cerebellar development revealed that excessive cell death under hypothyroidism was mediated via impaired neurotrophin signaling and increased mitochondrial dysfunction.30-33 At a cellular level, hypothyroidism during early cerebellar development leads to decreased transcription and defective post-translational processing of neurotrophins, namely BDNF and nerve growth factor. This loss of neurotrophic support not only reduces the cell survival signaling but also increases the pro-apoptotic activity of a neurotrophin receptor, P75NTR, expressed on the cell surface of cerebellar granule cells.32 This finally culminates in mitochondrial dysfunction and activation of the intrinsic apoptotic cascade, leading to enhanced granule cell death.30 Although T4 supplementation within the critical window can significantly rescue the apoptotic events associated with hypothyroidism, the recovery is not perfect. Therefore, we wanted to investigate other combinatorial agents that could help to rescue the defects of hypothyroidism. In this regard, administration of omega-3-fatty acids in hypothyroid pups significantly reduced the phenotypic alteration observed in a hypothyroid cerebellum.34 Omega-3-fatty acids, which are known neuroprotective agents35 showed that they, independently of circulating TH levels, reversed the effects of hypothyroidism on cerebellar genes, neurotrophin levels, and neuronal apoptosis.34 It is not clear how omega-3-fatty acids crosstalk with T3 genomic signaling, but it is most likely that omega-3-fatty acid-binding nuclear receptors, such as LXRs could interact with unliganded THRs.36 We also investigated the effect of combinatorial administration of iodine and omega-3 fatty acids in a rat model of hypothyroxinaemia.37 Hypothyroxinemia is characterized by normal thyroid-stimulating hormone concentration but low free thyroxine (FT4) concentration. The results of this study showed that supplementation of omega-3 fatty acids along with iodine improves neuronal architecture, neuronal survival, motor coordination, and memory function better than with either of them alone.37 Therefore, given their cooperative effect on iodine supplementation-mediated correction of neurological defects,37 further studies using omega-3-fatty acid along with iodine/T4 replacement regimen should be tested to see if this can correct neuronal defects even beyond the critical window of TH action.

Epigenetic modifiers as a therapeutic option to prevent hypothyroidism-induced neurodevelopmental defects

Given the ontogenesis of THRs in the developing brain, it was widely presumed that liganded THRs mediate the physiological effects of TH during brain development. To verify this presumption, THRα/β knock-out mouse models were generated, which were supposed to mimic the hypothyroid phenotype since they lacked THRs.38 Paradoxically, these animals did not mimic hypothyroid animals phenotypically and displayed normal brain structure and function.38 This discrepancy suggested that the unliganded THRs may play a central role in mediating the phenotypic changes of hypothyroidism during brain development.39 Since HDACs associated with unliganded THRs can repress the transcription of T3-regulated genes,40 we tested if an HDAC inhibitor can induce the derepression of T3 target genes and developmental processes under hypothyroidism. Using the rat model of perinatal hypothyroidism, we demonstrated that administration of sodium valproate, which is an HDAC inhibitor, in hypothyroid rat pups not only caused a derepression of TH target genes like Bdnf, Pcp2, and Mbp but also improved the dendritic structure of cerebellar Purkinje neurons41 [Figure 2]. Furthermore, a significant improvement in hypothyroidism-induced motor and cognitive defects was also observed.41 A recent follow-up study done by Susteyo et al.42(2022), further supported our findings wherein they used a specific HDAC3 inhibitor, RGFP966, and demonstrated significant rescue of cerebellar neuro-architecture and motor coordination defects in perinatal hypothyroid mice.42 Therefore, collectively, these findings indicate that HDAC3 plays an important role in the cerebellar developmental defects induced by perinatal hypothyroidism. Further evidence for the role of epigenetic silencing of T3-responsive developmental processes was observed in embryonic neocortical development, where delayed astrogliogenesis was associated with increased DNA methylation coupled with decreased histone acetylation at the Gfap promoter, leading to suppression of Gfap expression under maternal hypothyroidism.43 Therefore, these studies provide an insight into the role of epigenetic silencing of neurodevelopmental genes under TH insufficiency and provide a proof-of-concept to use epigenetic modulators to rescue iodine deficiency/hypothyroidism-induced neurological deficit both within and perhaps even beyond the critical window of TH action, which remains to be explored.

HDAC inhibitor Valproate (VPA) restores neuronal architecture in the hypothyroid cerebellum. (a and b) Photomicrographs showing Golgi stained Purkinje neurons of the cerebellar region in each study group at different magnifications. Red arrows denote the dendritic tree structures of Purkinje cells. (a) Magnification level 40× and (b) magnification level 100×. (Reproduced by permission from: https://pubmed.ncbi.nlm.nih.gov/26427529/).
Figure 2:
HDAC inhibitor Valproate (VPA) restores neuronal architecture in the hypothyroid cerebellum. (a and b) Photomicrographs showing Golgi stained Purkinje neurons of the cerebellar region in each study group at different magnifications. Red arrows denote the dendritic tree structures of Purkinje cells. (a) Magnification level 40× and (b) magnification level 100×. (Reproduced by permission from: https://pubmed.ncbi.nlm.nih.gov/26427529/).

CONCLUSION

The studies of our group listed in this manuscript provide evidence that maternal and postnatal premature TH deficiency comprehensively affects brain development. This includes forming neuronal progenitor pools, symmetrical and asymmetrical division, neuronal migration, transcriptional indices, and migration polarity. Thus, we show that iodine deficiency disorders of the whole spatial-temporal aspects of brain development result in compromised learning and mental faculties. In addition to demonstrating that the timely replacement of TH/iodine to some degree can correct both structural and functional integration, leading to restoration of memory, learning, and neurobehavioral paradigms, we also attempted to search for molecules that can even overcome the threshold of the critical developmental window. We present significant roles of HDACs in mediating the pathogenic effects of hypothyroidism and suggest that the HDAC inhibitors could be used as a new therapeutic strategy for cerebellar development defects. We have provided sufficient justification for the use of omega-3 fatty acid-iodine as a neutral carrier for the treatment of stunted hypothyroid children beyond the critical window of cerebellar development. We hope that our findings will lead to a comprehensive clinical trial making use of these modalities soon.

Acknowledgment

This work was supported by grants from Government of India, Department of Science and Technology, grants DST/FIST/LS-II/012/2003, DST-SERC (SR/SO/HS/95/2007 and SR/SO/HS-0054/2010 to M.M.G.); The thyroid hormone related developmental neurosciences work was initiated by Dr Naibedya Chattopadhyay, presently head endocrinology, CDRI Lucknow followed by Dr Rajesh Singh presently professor of Biochemistry at MS University Vadodara and Banaras Hindu University, Varanasi. Their contribution is gratefully acknowledged. Use of research resource from KLE University, Belagavi, Karnataka is also acknowledged.

Authors' contributions

MMG, RAS: Conceptualization, design, literature search, manuscript preparation; AP, AP, PK, and VM: Manuscript reviewing and editing.

Ethical approval

Institutional Review Board approval is not required.

Declaration of patient consent

Patient's consent not required as there are no patients in this study.

Financial support and sponsorship

Nil.

Conflicts of interest

Dr. Amit Pal is the employee of All Biosciences Research Pvt Ltd, Haryana, India.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , . Iodine and iodine deficiency: A comprehensive review of a re-emerging issue. Nutrients. 2022;14:3474.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  2. , , , , , , et al. Assessment of iodine nutrition of schoolchildren in Gonda, India, indicates improvement and effectivity of salt iodisation. Public Health Nutr. 2021;24:6211-7.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  3. . The disorders induced by iodine deficiency. Thyroid. 1994;4:107-28.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , . Thyroid hormone transporters in the brain. Rev Neurosci. 2010;21
    [CrossRef] [Google Scholar]
  5. , , . 5?-Monodeiodinase activity in developing human cerebral cortex. Am J Clin Nutr. 1993;57:291. S-4
    [Google Scholar]
  6. , , , . The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci U S A. 1997;94:10391-6.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  7. , , , , , , et al. Iodothyronine levels in the human developing brain: Major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab. 2004;89:3117-28.
    [CrossRef] [PubMed] [Google Scholar]
  8. , . The type 3 Deiodinase is a critical modulator of thyroid hormone sensitivity in the fetal brain. Front Neurosci. 2021;15:703730.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  9. , . , , eds. Thyroid Hormone Disruption and Neurodevelopment. New York: Springer; . p. :3-21.
  10. , , . Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci. 1992;12:2288-302.
    [CrossRef] [PubMed] [Google Scholar]
  11. , , , , , , et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929-47.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  12. , , , . Differential expression of alpha- and beta-thyroid hormone receptor genes in the developing rat brain under hypothyroidism. Biol Neonate. 1995;67:64-71.
    [CrossRef] [PubMed] [Google Scholar]
  13. . Non-genomic actions of thyroid hormone in brain development. Steroids. 2008;73:1008-12.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  14. , , , , . Integrin alphavbeta3 and thyroid hormones promote expansion of progenitors in embryonic neocortex. Development. 2014;141:795-806.
    [CrossRef] [PubMed] [Google Scholar]
  15. , , , , , . Maternal Thyroid hormone: A strong repressor of neuronal nitric oxide synthase in rat embryonic neocortex. Endocrinology. 2008;149:4396-401.
    [CrossRef] [PubMed] [Google Scholar]
  16. , , , , . Maternal thyroid hormone before the onset of fetal thyroid function regulates reelin and downstream signaling cascade affecting neocortical neuronal migration. Cereb Cortex. 2011;21:11-2.
    [CrossRef] [PubMed] [Google Scholar]
  17. , , , , , , et al. Maternal thyroid hormone deficiency affects the fetal neocorticogenesis by reducing the proliferating pool, rate of neurogenesis and indirect neurogenesis. Exp Neurol. 2012;237:477-88.
    [CrossRef] [PubMed] [Google Scholar]
  18. . Congenital hypothyroidism: Long-term outcome. Thyroid. 1999;9:741-8.
    [CrossRef] [PubMed] [Google Scholar]
  19. . Thyroid hormone regulated genes in cerebral cortex development. J Endocrinol. 2017;232:R83-97.
    [CrossRef] [PubMed] [Google Scholar]
  20. , , . An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: Etiological implications for Autism. Front Endocrinol. 2014;5
    [CrossRef] [Google Scholar]
  21. , . Molecular and cellular evolution of corticogenesis in amniotes. Cell Mol Life Sci. 2020;77:1435-60.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  22. , , , . Deficiency of the thyroid hormone transporter monocarboxylate transporter 8 in neural progenitors impairs cellular processes crucial for early corticogenesis. J Neurosci. 2017;37:11616-31.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  23. , , , . Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci. 1999;19:3430-9.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  24. , , , , , , et al. Early maternal hypothyroxinemia alters histogenesis and cerebral cortex cytoarchitecture of the progeny. J Clin Invest. 2003;111:1073-82.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  25. , , , , , . A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology. 2004;145:4037-47.
    [CrossRef] [PubMed] [Google Scholar]
  26. , , , , , , et al. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell. 1999;97:689-701.
    [CrossRef] [PubMed] [Google Scholar]
  27. , , , , , , et al. Thyroid hormone regulates reelin and dab1 expression during brain development. J Neurosci. 1999;19:6979-93.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  28. , , , , , et al. Thyroid hormone action controls multiple components of cell junctions at the ventricular zone in the newborn rat brain. Front Endocrinol (Lausanne). 2023;14:1090081.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  29. , . Neurotrophins promote the survival and development of neurons in the cerebellum of hypothyroid rats in vivo. J Cell Biol. 1996;133:631-46.
    [CrossRef] [PubMed] [Google Scholar]
  30. , , . Hypothyroidism alters mitochondrial morphology and induces release of apoptogenic proteins during rat cerebellar development. J Endocrinol. 2003;176:321-9.
    [CrossRef] [PubMed] [Google Scholar]
  31. , , , , , , et al. Hypothyroidism alters the expression of Bcl-2 family genes to induce enhanced apoptosis in the developing cerebellum. J Endocrinol. 2003;176:39-46.
    [CrossRef] [PubMed] [Google Scholar]
  32. , , , , , . Enhanced neuronal loss under perinatal hypothyroidism involves impaired neurotrophic signaling and increased proteolysis of p75(NTR) Mol Cell Neurosci. 2009;40:354-64.
    [CrossRef] [PubMed] [Google Scholar]
  33. , , , , , , et al. Evidence of a bigenomic regulation of mitochondrial gene expression by thyroid hormone during rat brain development. Biochem Biophys Res Commun. 2010;397:548-52.
    [CrossRef] [PubMed] [Google Scholar]
  34. , , , , , , et al. Anti-apoptotic role of omega-3-fatty acids in developing brain: Perinatal hypothyroid rat cerebellum as apoptotic model. Int J Dev Neurosci. 2009;27:377-83.
    [CrossRef] [PubMed] [Google Scholar]
  35. . Dietary omega 3 fatty acids and the developing brain. Brain Res. 2008;1237:35-43.
    [CrossRef] [PubMed] [Google Scholar]
  36. , , , , , , et al. Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression. Proc Natl Acad Sci U S A. 2004;101:10931-6.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  37. , , , , , , et al. Iodine plus n-3 fatty acid supplementation augments rescue of postnatal neuronal abnormalities in iodine-deficient rat cerebellum. Br J Nutr. 2013;110:659-70.
    [CrossRef] [PubMed] [Google Scholar]
  38. , , , , , , et al. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev. 1999;13:1329-41.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  39. , , , , , , et al. An unliganded thyroid hormone receptor causes severe neurological dysfunction. Proc Natl Acad Sci U S A. 2001;98:3998-4003.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  40. , . The in vivo role of nuclear receptor corepressors in thyroid hormone action. Biochim Biophys Acta. 2013;1830:3876-81.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  41. , , , , . Histone deacetylase inhibition reduces hypothyroidism-induced neurodevelopmental defects in rats. J Endocrinol. 2015;227:83-92.
    [CrossRef] [PubMed] [Google Scholar]
  42. , , , , . Histone deacetylase 3 inhibitor alleviates cerebellar defects in perinatal hypothyroid mice by stimulating histone acetylation and transcription at thyroid hormone-responsive gene loci. Int J Mol Sci. 2022;23:7869.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  43. , , , , , , et al. Mechanisms involved in epigenetic down-regulation of Gfap under maternal hypothyroidism. Biochem Biophys Res Commun. 2018;502:375-81.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections